Adjusting for bias introduced by instrumental variable estimation in the Cox proportional hazards model.


Journal

Biostatistics (Oxford, England)
ISSN: 1468-4357
Titre abrégé: Biostatistics
Pays: England
ID NLM: 100897327

Informations de publication

Date de publication:
01 01 2019
Historique:
received: 22 05 2017
accepted: 27 10 2017
pubmed: 22 12 2017
medline: 30 8 2019
entrez: 22 12 2017
Statut: ppublish

Résumé

Instrumental variable (IV) methods are widely used for estimating average treatment effects in the presence of unmeasured confounders. However, the capability of existing IV procedures, and most notably the two-stage residual inclusion (2SRI) algorithm recommended for use in non-linear contexts, to account for unmeasured confounders in the Cox proportional hazard model is unclear. We show that instrumenting an endogenous treatment induces an unmeasured covariate, referred to as an individual frailty in survival analysis parlance, which if not accounted for leads to bias. We propose a new procedure that augments 2SRI with an individual frailty and prove that it is consistent under certain conditions. The finite sample-size behavior is studied across a broad set of conditions via Monte Carlo simulations. Finally, the proposed methodology is used to estimate the average effect of carotid endarterectomy versus carotid stenting on the mortality of patients suffering from carotid artery disease. Results suggest that the 2SRI-frailty estimator generally reduces the bias of both point and interval estimators compared to traditional 2SRI.

Identifiants

pubmed: 29267847
pii: 4753665
doi: 10.1093/biostatistics/kxx062
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

80-96

Subventions

Organisme : FDA HHS
ID : U01 FD005478
Pays : United States

Auteurs

Pablo Martínez-Camblor (P)

The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine, Dartmouth College, 7 Lebanon Street, Suite 309, Hinman Box 7251, Hanover, NH, USA.

Todd Mackenzie (T)

Department of Biomedical Data Science, Geisel School of Medicine, Dartmouth College, The Dartmouth Institute for Health Policy and Clinical Practice, Hanover, NH, USA.

Douglas O Staiger (DO)

Department of Economics, Dartmouth College, The Dartmouth Institute for Health Policy and Clinical Practice, Hanover, NH, USA.

Philip P Goodney (PP)

Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, The Dartmouth Institute for Health Policy and Clinical Practice, Hanover, NH, USA.

A James O'Malley (AJ)

Department of Biomedical Data Science, Geisel School of Medicine, Dartmouth College, The Dartmouth Institute for Health Policy and Clinical Practice, Hanover, NH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH